Intercept Pharmaceuticals, Inc. (ICPT) has a consensus analyst rating of Hold, based on 40 analysts covering the stock. Of those, 16 recommend buying, 19 recommend holding, and 5 recommend selling.
The analyst consensus price target for ICPT is $22.11, representing a +16.4% upside from the current price of $19. Price targets range from a low of $10.00 to a high of $44.00.
